We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+17.28%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$942M
AUM Growth
+$65.9M
Cap. Flow
-$40.6M
Cap. Flow %
-4.31%
Top 10 Hldgs %
17.62%
Holding
1,095
New
434
Increased
124
Reduced
144
Closed
391

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$20.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.1M
3
QCOM icon
Qualcomm
QCOM
+$13.7M
4
DDOG icon
Datadog
DDOG
+$9.59M
5
XOM icon
ExxonMobil
XOM
+$8.72M

Sector Composition

Rank Sector Weight
1 Technology 26.27%
2 Consumer Discretionary 12.98%
3 Healthcare 12.92%
4 Financials 8.55%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HELE icon
276
Helen of Troy
HELE
$674M
$812K 0.09%
+6,725
New +$725K
TXG icon
277
10x Genomics
TXG
$8.45B
$811K 0.09%
14,500
+2,700
+23% +$117K
NVR icon
278
NVR
NVR
$17B
$805K 0.09%
115
-215
-65% -$1.33M
BE icon
279
Bloom Energy
BE
$64.2B
$788K 0.08%
+53,253
New +$666K
CTLT
280
DELISTED
CATALENT, INC.
CTLT
$788K 0.08%
17,533
-23,600
-57% -$955K
TAP icon
281
Molson Coors Class B
TAP
$7.77B
$783K 0.08%
+12,800
New +$769K
CPRT icon
282
Copart
CPRT
$30.3B
$781K 0.08%
+15,932
New +$753K
S icon
283
SentinelOne
S
$7.79B
$776K 0.08%
28,285
-191,700
-87% -$3.71M
CPB icon
284
Campbell Soup
CPB
$6.94B
$773K 0.08%
17,880
-112,311
-86% -$4.62M
HLF icon
285
Herbalife
HLF
$1.29B
$771K 0.08%
50,500
-9,300
-16% -$128K
BILI icon
286
Bilibili
BILI
$7.02B
$761K 0.08%
62,500
+40,339
+182% +$527K
MRK icon
287
Merck
MRK
$369B
$752K 0.08%
+6,900
New +$716K
XLP icon
288
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$749K 0.08%
10,400
+2,588
+33% +$179K
PD icon
289
PagerDuty
PD
$974M
$745K 0.08%
+32,168
New +$696K
FROG icon
290
JFrog
FROG
$12.8B
$743K 0.08%
21,458
+4,700
+28% +$127K
TTD icon
291
Trade Desk
TTD
$6.31B
$742K 0.08%
+10,312
New +$758K
IYR icon
292
iShares US Real Estate ETF
IYR
$4.6B
$739K 0.08%
8,086
-114
-1% -$9.33K
RMD icon
293
ResMed
RMD
$34B
$734K 0.08%
+4,265
New +$655K
BNTX icon
294
BioNTech
BNTX
$28B
$728K 0.08%
6,900
+700
+11% +$70.5K
SAIC icon
295
Saic
SAIC
$5.45B
$727K 0.08%
+5,844
New +$680K
COUR icon
296
Coursera
COUR
$1.69B
$726K 0.08%
37,500
-15,100
-29% -$289K
TECK icon
297
Teck Resources
TECK
$34.6B
$726K 0.08%
17,181
-8,400
-33% -$323K
HEI icon
298
HEICO Corp
HEI
$47.1B
$726K 0.08%
+4,058
New +$687K
RUN icon
299
Sunrun
RUN
$2.18B
$724K 0.08%
36,859
-64,484
-64% -$818K
BAX icon
300
Baxter International
BAX
$13.4B
$723K 0.08%
+18,700
New +$662K

Similar funds

Bayesian Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bayesian Capital Management held 1,095 positions worth $942M, up 7.5% from $876M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bayesian Capital Management withdrew a net $40.6M in Q4 2023, closing 391 positions and reducing 144 holdings. Its most notable exit was Palo Alto Networks, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $21.5M.

  • Bayesian Capital Management's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 45,200 shares worth $21.5M.
  • Bayesian Capital Management added most to Alibaba in Q4 2023, an estimated $20.3M increase.
  • Bayesian Capital Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $18.9M.
  • Bayesian Capital Management fully exited Palo Alto Networks in Q4 2023, selling an estimated $20M.
  • Bayesian Capital Management's ten largest holdings make up 18% of its $942M portfolio in Q4 2023.
  • Bayesian Capital Management opened 434 new positions and closed 391 in Q4 2023.
  • Bayesian Capital Management's portfolio value rose 7.5% quarter-over-quarter to $942M.

Based on Bayesian Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.